- Home
- LOMA vs VOR Comparison
LOMA vs VOR Comparison
Compare LOMA & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LOMA | VOR |
|---|---|---|
| Founded | 1926 | 2015 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LOMA | VOR |
|---|---|---|
| Price | $8.80 | $20.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 10 |
| Target Price | $14.00 | ★ $39.00 |
| AVG Volume (30 Days) | 398.3K | ★ 703.9K |
| Earning Date | 11-05-2026 | 10-30-2026 |
| Dividend Yield | ★ 1.11% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $25.29 | N/A |
| Revenue Next Year | $9.94 | N/A |
| P/E Ratio | $187.97 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.57 | $6.50 |
| 52 Week High | $13.20 | $26.00 |
Technical Indicators
Market Signals| Indicator | LOMA | VOR |
|---|---|---|
| Relative Strength Index (RSI) | 37.12 | 52.25 |
| Support Level | N/A | $17.44 |
| Resistance Level | $12.10 | $20.11 |
| Average True Range (ATR) | 0.34 | 1.20 |
| MACD | -0.05 | 0.11 |
| Stochastic Oscillator | 16.93 | 56.44 |
Price Performance
Historical ComparisonAbout LOMA Loma Negra Compania Industrial Argentina Sociedad Anonima ADS
Loma Negra Cia Industria Argentina SA is a cement producer in Argentina. The Group is engaged in the production and distribution of cement, masonry cement, concrete, limestone, and aggregates, operates a railway concession to provide transportation services, and is also engaged in the industrial waste recycling business. The company operates in five segments: Cement, masonry cement, and lime; Concrete; Rail services; Aggregates; and Others. The majority of its revenue derives from Cement, masonry cement, and lime segments.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.